Cathy Clark
Family · Jefferson, NCNPI 1215009758
Payments from drug & device makers
Across 61 payments — averaging $23.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$399
- Axsome Therapeutics, Inc.$143
- Merck$123
- Johnson & Johnson$76
- E.r. Squibb & Sons, L.L.C.$74
- Amgen$59
- plus $562 from 17 others
What the payments were for
- Food & beverage$1,24687%
- Education$18913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 11 | $399 |
| Axsome Therapeutics, Inc. | 4 | $143 |
| Merck | 6 | $123 |
| Johnson & Johnson | 3 | $76 |
| E.r. Squibb & Sons, L.L.C. | 4 | $74 |
| Amgen | 4 | $59 |
| Novartis | 3 | $58 |
| Bayer | 2 | $53 |
| AbbVie | 3 | $49 |
| Lilly USA, LLC | 3 | $48 |
| Novo Nordisk | 2 | $44 |
| Organon | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| GSK | 2 | $32 |
| Bristol Myers Squibb | 2 | $29 |
| Pfizer | 2 | $28 |
| Dexcom, Inc. | 1 | $26 |
| Array Biopharma Inc | 1 | $25 |
| Adaptive Biotechnologies Corporation | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Exelixis Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Irhythm Technologies, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Symbravo$119
How this compares
$1,435 in reported general payments places this provider in the 75th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TagrissoOsimertinib Mesylate | 20 | $345,806 |
| XtandiEnzalutamide | 13 | $190,192 |
| BrukinsaZanubrutinib | 15 | $160,050 |
| Lenalidomide | 12 | $121,888 |
| EliquisApixaban | 63 | $49,909 |
| ZenpepLipase/Protease/Amylase | 12 | $21,094 |
| JanuviaSitagliptin Phosphate | 20 | $20,462 |
| OzempicSemaglutide | 17 | $17,961 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $3,995 |
| SynthroidLevothyroxine Sodium | 19 | $2,137 |
| Potassium Chloride | 54 | $1,328 |
| Anagrelide Hcl | 11 | $1,059 |
| Levothyroxine Sodium | 143 | $919 |
| Pantoprazole Sodium | 74 | $890 |
| Gabapentin | 48 | $872 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi | $18 | $190,19213 claims |
| PfizerEliquis | $28 | $49,90963 claims |
| MerckJanuvia | $123 | $20,46220 claims |
| Novo NordiskOzempic | $44 | $17,96117 claims |
| GSKAnoro Ellipta | $32 | $3,99511 claims |
| AbbVieSynthroid | $49 | $2,13719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,522 family providers in North Carolina.
Other family in Jefferson
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.